189 related articles for article (PubMed ID: 16763275)
1. Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer?
Adelstein DJ; Leblanc M
J Clin Oncol; 2006 Jun; 24(17):2624-8. PubMed ID: 16763275
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy in head and neck cancer: should it be revisited?
Specenier PM; Vermorken JB
Cancer Lett; 2007 Oct; 256(2):166-77. PubMed ID: 17673364
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy of cisplatin and fluorouracil regimen in head and neck squamous cell carcinoma: a meta-analysis.
Su YX; Zheng JW; Zheng GS; Liao GQ; Zhang ZY
Chin Med J (Engl); 2008 Oct; 121(19):1939-44. PubMed ID: 19080128
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy: to use or not to use? That is the question.
Brizel DM; Vokes EE
Semin Radiat Oncol; 2009 Jan; 19(1):11-6. PubMed ID: 19028340
[TBL] [Abstract][Full Text] [Related]
6. Induction chemotherapy in locally advanced head and neck cancer: a new standard of care?
Lorch JH; Posner MR; Wirth LJ; Haddad RI
Hematol Oncol Clin North Am; 2008 Dec; 22(6):1155-63, viii. PubMed ID: 19010265
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
8. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?
McHam SA; Adelstein DJ; Rybicki LA; Lavertu P; Esclamado RM; Wood BG; Strome M; Carroll MA
Head Neck; 2003 Oct; 25(10):791-8. PubMed ID: 12966502
[TBL] [Abstract][Full Text] [Related]
9. [Role of Chemotherapy in head and neck cancer].
Kohno N; Kitahara S
Gan To Kagaku Ryoho; 2001 Apr; 28(4):448-53. PubMed ID: 11329777
[TBL] [Abstract][Full Text] [Related]
10. Induction chemotherapy for head and neck cancer: recent data.
Vokes EE
Oncologist; 2010; 15 Suppl 3():3-7. PubMed ID: 21036882
[TBL] [Abstract][Full Text] [Related]
11. Paradigm shift in the treatment of head and neck cancer: the role of neoadjuvant chemotherapy.
Posner MR
Oncologist; 2005; 10 Suppl 3():11-9. PubMed ID: 16368867
[TBL] [Abstract][Full Text] [Related]
12. Randomized trials of induction chemotherapy. A critical review.
Forastiere AA
Hematol Oncol Clin North Am; 1991 Aug; 5(4):725-36. PubMed ID: 1890063
[TBL] [Abstract][Full Text] [Related]
13. Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma.
Barone C; Grillo R; Dongiovanni D; Birocco N; Rampino M; Redda MG; Garibaldi E; Munoz F; Pecorari G; Cavalot A; Garzinodemo P; Buffoni L; Ciuffreda L; Ricardi U; Cortesina G; Giordano C; Fasolis M; Berrone S; Bertetto O; Schena M
Anticancer Res; 2008; 28(2B):1285-91. PubMed ID: 18505067
[TBL] [Abstract][Full Text] [Related]
14. [Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy].
Bardet E; Bourhis J; Cals L; Fayette J; Guigay J; Hans S; Saint-Guily JL; Lagarde F; Lallemant B; Milano G; Rolland F; Lefebvre JL
Bull Cancer; 2009 Oct; 96(10):1013-28. PubMed ID: 19744919
[TBL] [Abstract][Full Text] [Related]
15. Revisiting induction chemotherapy for head and neck cancer. References and reviews.
Argiris A; Jayaram P; Pichardo D
Oncology (Williston Park); 2005 Jun; 19(7):932-4, 939; discussion 939-45. PubMed ID: 16053039
[TBL] [Abstract][Full Text] [Related]
16. Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: a meta-analysis.
Ma J; Liu Y; Huang XL; Zhang ZY; Myers JN; Neskey DM; Zhong LP
Oral Oncol; 2012 Nov; 48(11):1076-84. PubMed ID: 22800881
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
[TBL] [Abstract][Full Text] [Related]
18. New options in the treatment of locally advanced head and neck cancer: role for induction chemotherapy.
Cruz JJ; Ocaña A; Navarro M; Barco ED; Fonseca E
Cancer Treat Rev; 2008 May; 34(3):268-74. PubMed ID: 18194842
[TBL] [Abstract][Full Text] [Related]
19. [The radiochemotherapy of advanced head-neck tumors--what is certain?].
Wendt TG
Strahlenther Onkol; 1996 Aug; 172(8):409-16. PubMed ID: 8765342
[TBL] [Abstract][Full Text] [Related]
20. Current and emerging standards of concomitant chemoradiotherapy.
Adelstein DJ; Rodriguez CP
Semin Oncol; 2008 Jun; 35(3):211-20. PubMed ID: 18544436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
